IVF Grant Program

The IVF Grant Program is a private funding opportunity created through a partnership between Caden Lane, The Prelude Network, and CooperSurgical, administered through their respective nonprofit organizations, The Conceive Fertility Foundation and The Wyatt Foundation. These organizations are mission-driven entities focused on addressing infertility challenges by expanding access to assisted reproductive technology. The Wyatt Foundation operates as the nonprofit arm of Inception Fertility, a major fertility services provider in North America, while The Conceive Fertility Foundation was established by Caden Lane to support individuals impacted by infertility through education and financial assistance. Together, these organizations aim to reduce the financial barriers associated with in vitro fertilization (IVF). The primary purpose of this grant program is to provide financial assistance to individuals and couples who require IVF treatment to build their families. The program acknowledges that infertility affects a significant portion of the population and that IVF costs can be prohibitive. To address this need, the program will award five grants of 15,000 dollars each, along with an additional 1,000 dollar genetic testing grant per recipient. These funds are intended to offset the cost of one IVF cycle, though they may not cover the full cost depending on individual treatment needs. Funding provided through this grant is restricted to IVF-related services and is not disbursed directly to recipients as cash. Instead, funds are paid directly to the fertility clinic selected by the recipient. While the grant primarily covers IVF procedures, any remaining funds after the core cycle cost may be applied toward related services such as medications, embryo testing, donor services, or storage fees. Recipients have the flexibility to choose their clinic; however, those who utilize clinics within The Prelude Network may receive a 10 percent discount on fertility services, which can help extend the value of the grant. Eligibility for the program is limited to individuals between the ages of 25 and 42 who have received a formal infertility diagnosis from a qualified OB/GYN or fertility specialist. Applicants must also demonstrate financial need by submitting a Form 1040 tax return showing income of no more than 100,000 dollars for individuals or 150,000 dollars for married couples. The program is inclusive in terms of marital status and allows applicants who have previously undergone fertility treatments, have secondary infertility, or plan to use donor eggs, sperm, or surrogacy arrangements. The application process requires submission of eligibility documentation, including proof of diagnosis and income verification. While the source does not list a full application checklist, applicants must apply by the stated deadline and will receive confirmation upon submission. The selection process is not random, indicating that applications are evaluated based on defined but unspecified criteria related to need and eligibility. Award recipients are announced during the week of July 27, 2026. The application timeline includes a firm submission deadline of June 22, 2026. Grants must be used within a defined timeframe, expiring on December 1, 2026, if not utilized. This creates a relatively short performance window for recipients to initiate and complete treatment. The program appears to operate on a recurring basis, as applicants are permitted to reapply in subsequent cycles, including those who have previously received funding. No specific contact person, phone number, or email is listed, and no official PDF guidelines are provided in the source material.

Ensure all financial and medical documentation is complete and accurate as selection is not random and based on demonstrated need